If You Bought or Provided Reimbursement for the Anticoagulant Medications Lovenox® or Generic Enoxaparin From September 21, 2011 through September 30, 2015. You Could Get Money from Class Action Settlements totaling $120 Million.

Settlements have been reached in a Class Action Lawsuit against Momenta Pharmaceuticals, Inc. and Sandoz Inc. (together called the “Defendants”) about the price that consumers, HOSPITALS, and third-party payors paid for Lovenox® or generic enoxaparin. The lawsuit asserts that Defendants kept the prices of Lovenox® and generic enoxaparin higher than they otherwise would have been by manipulating the generic approval process to bring within the scope of Defendant Momenta’s patents the testing of enoxaparin that is required to ensure every batch meets FDA standards. This means that although Momenta did not develop enoxaparin, it tried to use its patented processes for testing generic enoxaparin to prevent other generic drug manufacturers from selling it. The lawsuit also claims Momenta collaborated with Sandoz and knew that developing a scheme to monopolize the market would lead to record profits. The Defendants deny these claims.

Settlements totaling $120 million have been reached between the Class Plaintiffs (uninsured consumers, hospitals, and third-party payors) and the Defendants.

If you previously excluded yourself from the Class, you will receive no benefits, but you will retain any rights you currently have to sue the Defendants about the claims in this case.

No one is claiming that Lovenox® or generic enoxaparin are unsafe or ineffective.